Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients

por Palich, R., Veyri, M., Marot, S., Vozy, A., Gligorov, J., Maingon, P., Marcelin, A.-G., Spano, J.-P.
Publicado 2021

High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers

por Palich, R., Veyri, M., Vozy, A., Marot, S., Gligorov, J., Benderra, M.-A., Maingon, P., Morand-Joubert, L., Adjoutah, Z., Marcelin, A.-G., Spano, J.-P., Barrière, J.
Publicado 2021

1610P Humoral immune response to COVID-19 vaccination in patients with cancer: The ANRS0001S COV-POPART study

por Luong Nguyen, L.B., Chalouni, M., Loubet, P., Dohollou, N., Tredan, O., Veyri, M., Maakaroun-Vermesse, Z., Ben Ghezala, I., Fourn, E., Merrien, D., Cracowski, C., Barquin, A., Levier, A., Wittkop, L., Launay, O., Blay, J-Y., Spano, J-P.
Publicado 2022